Why the study?
What is the prevalence of dyslipoproteinemia and its associated clinical variables in premenopausal SLE patients compared to controls?
What is the prevalence of dyslipoproteinemia and its associated clinical variables in premenopausal SLE patients compared to controls?
Dyslipoproteinemia is highly prevalent in premenopausal SLE patients and is strongly associated with corticosteroid use and proteinuria.
No takes yet. Share an insight, caveat, or question.
May warrant lipid monitoring in premenopausal SLE; leaves open causal pathways involving proteinuria.
Formiga et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: